title: [Multiple neoplasms after a well succeeded treatment of Hodgkin's disease].
abstract: The authors refer to a 21-year-old Caucasian (white) woman, who in 1977 presented fever and cervical and axillary adenopathy, whose biopsy showed nodular sclerosis Hodgkin's Disease, stage IIIB. The patient received six chemotherapy cycles associated with immunotherapy and supplemented with radiation therapy with good response. RESULTS--In 1985, after routine gynaecological examination and a hysterectomy, cervical intraepithelial neoplasia grade 3 (CIN 3) and atypic leiomyoma of the uterine body were diagnosed. Five years later, biopsies diagnosed invasive duct carcinoma in the right breast and homolateral axillary and cervical nodes. The patient was submitted to chemo and radiation therapy and died nine months later. CONCLUSION--The possibility of later occurrence of a second or multiple new malignancies in patients successfully treated for Hodgkin's Disease points out the need for a more complete long-term follow-up, including periodic mammography.
authors.affiliation: Faculdade de Medicina, Triângulo Mineiro, Uberaba, MG.
authors.forename: H
authors.initials: H
authors.lastname: Moraes-Souza
authors.forename: D A
authors.initials: DA
authors.lastname: Nogueira
authors.forename: P R
authors.initials: PR
authors.lastname: Martins
authors.forename: M A
authors.initials: MA
authors.lastname: de Souza
authors.forename: M A
authors.initials: MA
authors.lastname: de Lima
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000139:chemically induced*; D018270:Carcinoma, Ductal, Breast / Q000139:chemically induced*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007889:Leiomyoma / Q000139:chemically induced*; D008466:Mechlorethamine / Q000008:administration & dosage / Q000009:adverse effects; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects; D012074:Remission Induction; D014594:Uterine Neoplasms / Q000139:chemically induced*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects; D002578:Uterine Cervical Dysplasia / Q000139:chemically induced*
chemical_list: D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone